DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in CAPD Patients

Information source: Chulalongkorn University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Peritonitis

Intervention: ceftazidime+ciprofloxacin (Drug); ceftazidime monotherapy (Drug); cefazolin+gentamicin (Drug); cefazolin monotherapy (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Chulalongkorn University

Official(s) and/or principal investigator(s):
Nalinee Saiprasertkit, MD., Principal Investigator, Affiliation: Chulalongkorn University

Overall contact:
Talerngsak Kanjanabuch, Assoc. Prof., Phone: 662-2564321, Ext: 211, Email: golfnephro@hotmail.com

Summary

To compare the efficacy of single versus combined antibiotic therapy for bacterial peritonitis in CAPD patients.

Clinical Details

Official title: Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Primary outcome: relapse or recurrent rate

Detailed description: To compare relapse and recurrent rate of peritonitis between single and combined antibiotic regimens for bacterial peritonitis in CAPD patients.

Eligibility

Minimum age: 15 Years. Maximum age: 75 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- age >/= 18 years old

- ESRD patients on continuous ambulatory peritoneal dialysis more than 4 weeks

- presence of symptom or sign of peritonitis

- presence of WBC >100cell/mm3 with PMN >50% in peritoneal dialysate or gram stain

positive for gram positive or gram negative bacteria Exclusion Criteria:

- presence of polymicrobial organism, non-fermentative gram negative organism, fungus,

mycobacteria in peritoneal fluid or culture-negative

- peritonitis from the organisms that required combined antibiotic therapy according to

ISPD guideline 2010

- hospital-acquired peritonitis

- presence of catheter-related infection

- history of peritonitis within 4 weeks

- currently taking antibiotic

- allergic to the antibiotic that used in the study(penicillin or cephalosporin or

quinolone or aminoglycoside)

Locations and Contacts

Talerngsak Kanjanabuch, Assoc. Prof., Phone: 662-2564321, Ext: 211, Email: golfnephro@hotmail.com

Chulalongkorn university, Bangkok 10330, Thailand; Recruiting
Nalinee Saiprasertkit, MD., Phone: 66865899700, Email: nsaiprasertkit@gmail.com
Nalinee Saiprasertkit, MD., Principal Investigator
Worapot Treamtrakanpon, MD., Sub-Investigator
Additional Information

Starting date: December 2012
Last updated: February 6, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017